Use of cannabinoids in the treatment of epilepsy
US-12064399-B2 · Aug 20, 2024 · US
US10870619B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10870619-B2 |
| Application number | US-201716469852-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 29, 2017 |
| Priority date | Dec 30, 2016 |
| Publication date | Dec 22, 2020 |
| Grant date | Dec 22, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application relates to a method for preparing L-methionine crystals with an improved bulk density. As the L-methionine crystals prepared according to the method for preparing L-methionine crystals of the present application may have a bulk density of up to 800 g/L, the L-methionine crystals are expected to reduce storage and transport costs of L-methionine powder and improve working conditions due to improved fluidity of the powder.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing L-methionine crystals, comprising: (a) adding a pH control agent to an aqueous solution comprising L-methionine to lower or increase the pH, a step of pH adjustment; (b) heating the aqueous solution comprising L-methionine, a step of heat treatment; (b-2) adding a pH control agent to the aqueous solution comprising L-methionine to increase or lower the pH, a step of pH readjustment, between Step (b) and Step (c) or in Step (c); and (c) extracting L-methionine crystals from the aqueous solution comprising L-methionine, which underwent pH adjustment and heat treatment, a step of extraction of crystals. 2. The method according to claim 1 , further comprising Step (b-1): adding a coagulant to the aqueous solution comprising L-methionine, a step of addition of a coagulant, before Step (b-2). 3. The method according to claim 1 , further comprising Step (b-3): cooling the aqueous solution comprising L-methionine, a step of cooling, before or during Step (c). 4. The method according to claim 1 , wherein when the pH control agent in the step of pH adjustment is a pH-increasing agent, the pH control agent in the step of pH readjustment is a pH-lowering agent, and when the pH control agent in the step of pH adjustment is a pH-lowering agent, the pH control agent in the step of pH readjustment is a pH-increasing agent. 5. The method according to claim 2 , wherein the coagulant is an aromatic compound. 6. The method according to claim 5 , wherein the aromatic compound is at least one compound selected from the group consisting of acetylsalicylic acid, acetaminophen, benzoic acid, salicylic acid, gallic acid, L-tyrosine, and L-phenylalanine. 7. The method according to claim 2 , wherein the coagulant is added in an amount of 2 to 7 parts by weight relative to 100 parts by weight of L-methionine. 8. The method according to claim 1 , wherein the step of heat treatment is to heat to a temperature of 40° C. to 90° C. 9. The method according to claim 3 , wherein the step of cooling is to cool to a temperature of 15° C. to 35° C. 10. The method according to claim 3 , wherein the step of cooling is performed at a rate of 20° C./h or less. 11. The method according to claim 2 , wherein when the pH control agent in the step of pH adjustment is a pH-increasing agent, the pH control agent in the step of pH readjustment is a pH-lowering agent, and when the pH control agent in the step of pH adjustment is a pH-lowering agent, the pH control agent in the step of pH readjustment is a pH-increasing agent.
by reactions not involving the formation of sulfide groups · CPC title
Crystalline forms, e.g. polymorphs · CPC title
General arrangements of crystallisation plant, e.g. flow sheets · CPC title
Use of anti-solvent · CPC title
Evaporation of components of the mixture to be separated · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.